Working Together to Understand, Protect and Restore Vision
The McPherson Eye Research Institute celebrated its 10th Anniversary with the 4th Annual Endowed Lecture on Thursday, April 28, 2016. Pawan Sinha, PhD, Professor of Vision and Computational Neuroscience in the Department of Brain and Cognitive Sciences at MIT, spoke about “Learning to See Late in Childhood.” His lecture focused on Project Prakash – an initiative restoring sight to blind children …
4th Annual Endowed Lecture – Thursday, April 28, 2016 DeLuca Biochemical Sciences Building, Room 1211
Waisman Biomanufacturing and McPherson Eye Research Institute held this day-long workshop on March 17, 2016, at The Wisconsin Institute for Discovery, Madison, WI (8:00 am – 6:30 pm). The development of cell therapies for ocular diseases from basic research to clinical studies was presented and discussed, including: the development of cells for drug screening applications, …
MERI-at-a-Glance successfully took place on February 19th at the Wisconsin Institute of Discovery (WID), where eight short research talks were presented. Vision-related findings and interests were shared from cataracts and glaucoma, viral gene delivery to therapeutic stem cell interventions, and computational optics to toddlers and TV. These McPherson ERI members presented at MERI-at-a-Glance: Ariel Alperstein, …
Tuesday, January 12, 2016 – WIMR Conference room 7001A Toward Saving Sight Tuesday, February 9, 2016 – Genetics/Biotechnology Center room 1360 Therapeutic Potential of Stem Cells Tuesday, March 8, 2016 – (WIMR Conference room 7001A) Recipients: Christenson AMD Fund/Morgridge Institute for Research Award & Walsh Travel Award Tuesday, April 12, 2016 – …
Gillian McLellan (Ophthalmology) is shown here checking out the eyes of a rare human/Mustelidae hybrid at a Badger hockey game in November. The creature, fully recovered, later posed with McPherson ERI Director David Gamm.
In a study released today, researchers from a variety of institutions – including the Marshfield Clinic, whose director, Dr. Murray Brilliant, is the lead author of the study – have announced that patients who use the drug L-DOPA, commonly used for Parkinson’s Disease and other movement disorders, are “significantly less likely to develop Age-related Macular …
7th Annual Vision Science Poster Session & Lecture Tuesday, November 3rd, 2015; HSLC Atrium Professors Susana Martinez-Conde & Stephen Macknik State University of New York (SUNY) Downstate Medical Center, Laboratory of Integrative Neuroscience Sleights of Mind: What the Neuroscience of Magic Reveals About our Everyday Deceptions
A New Study from McPherson ERI Members & Collaborators Shows That Patients Taking the Drug L-DOPA are Significantly Less Likely to Develop Age-related Macular Degeneration (AMD). Read more